Consistent with the in vitro cytotoxicity assay, MUC1/CD3 BsAb treatment can significantly inhibit MUC1-positive tumor cell growth in the xenograft mouse model (Figure 4B,C). This evidence concerns the gene MUC1 and neoplasm.